Brief: Enanta Pharmaceuticals Reports Financial Results For Second Quarter

Enanta Pharmaceuticals

08/05/2023 22:28

May 8 (Reuters) - Enanta Pharmaceuticals Inc  ENTA.O :
    * ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS
FISCAL
SECOND QUARTER 
    * ENANTA - ON TRACK TO REPORT PHASE 1 DATA OF EDP-323 IN
JUNE
    * ROYALTY REVENUE FOR QUARTER WAS $17.8 MILLION
    * CASH, CASH EQUIVALENTS AND SHORT-TERM AND LONG-TERM
MARKETABLE
SECURITIES TOTALED $225.1 MILLION AT MARCH 31, 2023
    * ENANTA- SEES CURRENT CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES & OTHERS WILL MEET ANTICIPATED CASH REQUIREMENTS OF
BUSINESS, DEVELOPMENT PROGRAMS INTO 2026
    * QTRLY LOSS PER SHARE $1.79
    * Q2 EARNINGS PER SHARE VIEW $-1.98 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw5FblXWa 
Further company coverage:  ENTA.O 

 ((Reutersbriefs@thomsonreuters.com;))